Showing results (1121-1130 of 9,240) with videos related to
Sort By:
Pageof 924
The Journal of Pharmacy and Pharmacology|January 25, 2003
Synthesis and radical scavenging of novel magnolol derivativesYvonne Wang, Chi-Yuan Li, I-Hshin Lin, et al.The Journal of Pharmacy and Pharmacology|October 3, 2002
Rapid determination of vitamin C by NIR, MIR and FT-Raman techniquesHong Yang, Joseph IrudayarajThe Journal of Pharmacy and Pharmacology|May 10, 2002
In-vitro release and oral bioactivity of insulin in diabetic rats using nanocapsules dispersed in biocompatible microemulsionSuchat Watnasirichaikul, Thomas Rades, Ian G Tucker, et al.The Journal of Pharmacy and Pharmacology|May 10, 2002
Cloned human EP1 prostanoid receptor pharmacology characterized using radioligand binding techniquesNajam A Sharif, Terry L DavisThe Journal of Pharmacy and Pharmacology|May 10, 2002
A study of the substrate specificity of Na+-dependent and Na+-independent neutral amino acid transport systems in dog intestinal brush-border membrane vesicles using L-alanine analoguesTakahiro Hatanaka, Yoshiaki Nabuchi, Hidetoshi UshioThe Journal of Pharmacy and Pharmacology|May 24, 2001
St John's wort (Hypericum perforatum L.): a review of its chemistry, pharmacology and clinical propertiesJ Barnes, L A Anderson, J D PhillipsonThe Journal of Pharmacy and Pharmacology|May 24, 2001
Tissue distribution of radioactivity following intranasal administration of radioactive microspheresJ E Eyles, I D Spiers, E D Williamson, et al.The Journal of Pharmacy and Pharmacology|May 24, 2001
In-vivo kinetics of the interaction between midazolam and erythromycin in rats, taking account of metabolic intermediate complex formationS Takedomi, H Matsuo, K Yamano, et al.The Journal of Pharmacy and Pharmacology|May 24, 2001
Synthesis of flavonoids and their effects on aldose reductase and sorbitol accumulation in streptozotocin-induced diabetic rat tissuesS S Lim, S H Jung, J Ji, et al.The Journal of Pharmacy and Pharmacology|May 24, 2001
Design, synthesis and biological evaluation of a sulfonylcyanoguanidine as thromboxane A2 receptor antagonist and thromboxane synthase inhibitorJ M Dogné, J Wouters, S Rolin, et al.Pageof 924